Polymers and Nanomaterials for Gene Therapy provides the latest information on gene therapy, a topic that has attracted significant attention over the past two decades for the treatment of inherited and acquired genetic diseases. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy.
The book explores the most recent developments in the field of polymer science and nanotechnology, and how these advancements have helped in the design of advanced materials. Non-viral vector systems, including cationic lipids, polymers, dendrimers, peptides and nanoparticles, are potential routes for compacting DNA for systemic delivery. However, unlike viral analogues that have no difficulty in overcoming cellular barriers and immune defense mechanisms, non-viral gene carriers consistently exhibit significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Therefore, biocompatibility and potential for large-scale production make these compounds increasingly attractive for gene therapy.
This book contains chapters on the engineering of polymers and nanomaterials for gene therapy, and how they can form complexes with DNA and avoid both in vitro and in vivo barriers. Other chapters describe in vitro, ex vivo, in vivo gene therapy studies, and the current issues affecting non-viral gene therapy.
- Explores current challenges in the research of genetic diseases
- Discusses polymers for gene therapy and their function in designing advanced materials
- Provides examples of organic and inorganic nanomaterials for gene therapy
- Includes labeling, targeting, and assays
- Looks at characterization, physico-(bio)chemical properties, and applications
Ravin Narain, PhD, PEng, FRSC, is a Professor at the Department of Chemical and Materials Engineering in the University of Alberta, Edmonton, AB, Canada. Prof. Narain has made significant contributions to research on the
design, fabrication, and characterization of novel carbohydrate-based materials (glycopolymers, hydrogels, and nanomaterials) for a wide range of applications. His research has also covered biomaterials, nanomedicines, and regenerative medicines, with an emphasis on developing advanced materials as cancer therapeutics, antifouling and antimicrobial uses, and cell/tissue engineering advances. He has published numerous articles in peerreviewed
and high-impact journals and has edited several books, namely, Engineered Carbohydrate-Based Materials for Biomedical Applications (Wiley), Chemistry of Bioconjugates (Wiley), Glycopolymers: Synthesis and Applications (Smithers & Rapra), Polymers and Nanomaterials for Gene Therapy (Woodhead Publishing Elsevier), and Polymer Science and Nanotechnology (Elsevier). He was recently the section editor for the second edition of the book―Comprehensive Glycoscience (Elsevier). He is also on the editorial board for Frontiers in
Chemistry (Polymer Chemistry), Polymer Chemistry (RSC), Biomacromolecules (ACS), and Polymers (MDPI). He has won several awards including the Distinguished Visiting Researcher Award from Commonwealth Scientific and Industrial Research Organization (CSIRO), Australia.
